Product Images Alendronate

Not available.*

The text contains a table with the columns "Change in BMD from Baseline 2-Year Study" and "Change in BMD from Baseline 3-Year Study" and rows of data labelled "Alendronate Sodium 5mg/day" and "Placebo". The table shows percentages of mean change in BMD in different parts of the body including spine, neck, body, femoral trochanter, and total. There is no clear description or purpose provided for this data.*

The text appears to be a table or chart showing the increase in bone mineral density (BMD) for patients with glucocorticoid treatment who were given the medication Alendronate at a dose of 5 mg/day for one year. The table shows the mean 9% increase in BMD relative to a placebo, with separate increases shown for the lumbar spine, femoral neck, and trochanter. This information is likely from a clinical trial or study evaluating the efficacy of Alendronate in improving BMD in patients with glucocorticoid treatment.*

This text appears to be a part of a study on Paget's disease of bone. The study evaluates the effect of Alendronate 40mg/day on serum alkaline phosphatase compared to Placebo or Etidronate 400mg/day. The study is a multinational trial and a US Study. The graph shows the results at different time intervals (in months).*

This is a description for Alendronate Sodium Tablets, USP 35 mg. It is a weekly medication for adults who suffer from osteoporosis. It contains 12 tablets per package and each tablet is 35mg in strength. The recommended dosage is one 35mg tablet per week, accompanied by a glass of water. The drug comes with a prescription label and should only be dispensed by a pharmacist. The medication is manufactured by Mtx Pharmaceuticals in New Castle, CA and distributed in the USA.*

This appears to be a product label for Alendronate Sodium Tablets, used to treat bone loss. The label includes dosage instructions, manufacturer information, and warnings about potential side effects. It is recommended to store the medication at room temperature.*

This appears to be a description of a medication called "Alendronate Sodium Tablets". Each tablet contains 70mg of the active ingredient, sodium alendronate, and is meant to be taken once a week as indicated on the prescription label. The manufacturer is listed as Marx Pharmaceuticals and the tablets come in a pack of 12. The rest of the text is illegible or fragmented and is not-usable to generate any further information.*

This is the description: "Once Weekly Alendronate Sodium Tablets, USP 70 mg is a medication manufactured by Marx Pharmaceuticals. It comes in tablet form and is intended for adults. The usual adult dosage of this medication is one 70 mg tablet once a week. It contains 1.37 mg of alendronate sodium per tablet. This medication requires a prescription label. For further information, refer to the enclosed medication guide. Keep all drugs out of reach of children and store at 20°-25°C (68-77°F) with excursions permitted to 15°-30°C (59°-86°F)."*